We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
+18.31%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.72B
AUM Growth
+$244M
Cap. Flow
+$33.9M
Cap. Flow %
1.25%
Top 10 Hldgs %
66.52%
Holding
104
New
19
Increased
17
Reduced
17
Closed
18

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$53.9M
2
WW
WW International
WW
+$15.8M
3
MA icon
Mastercard
MA
+$13.3M
4
DAL icon
Delta Air Lines
DAL
+$11.5M
5
FSL
FREESCALE SEMICONDUCTOR LTD
FSL
+$7.47M

Top Sells

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$21.5M
2
AMZN icon
Amazon
AMZN
+$16.2M
3
C icon
Citigroup
C
+$15.1M
4
TEX icon
Terex
TEX
+$8.22M
5
ACOR
Acorda Therapeutics
ACOR
+$5.47M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33%
2 Healthcare 20.75%
3 Financials 0.8%
4 Technology 0.57%
5 Industrials 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WW
1
DELISTED
WW International
WW
$808M 29.73%
29,443,300
+694,211
+2% +$15.8M
LXRX icon
2
Lexicon Pharmaceuticals
LXRX
$1.03B
$357M 13.15%
36,196,019
– –
SPY icon
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$236M 8.7%
1,200,000
+200,000
+20% +$39.5M
IWM icon
4
CALL
iShares Russell 2000 ETF
IWM
$79.1B
$87.5M 3.22%
800,000
+600,000
+300% +$68.6M
AUXL
5
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$67.9M 2.5%
2,275,000
+1,175,000
+107% +$24.9M
BABA icon
6
Alibaba
BABA
$276B
$53.3M 1.96%
+600,000
New +$53.9M
BMY icon
7
CALL
Bristol-Myers Squibb
BMY
$129B
$51.2M 1.88%
1,000,000
+200,000
+25% +$9.99M
GWW icon
8
CALL
W.W. Grainger
GWW
$64.2B
$50.3M 1.85%
+200,000
New +$49.1M
MET icon
9
CALL
MetLife
MET
$62.4B
$48.3M 1.78%
1,009,800
– –
MRK icon
10
CALL
Merck
MRK
$322B
$47.4M 1.75%
838,400
-524,000
-38% -$29.4M
BIIB icon
11
CALL
Biogen
BIIB
$30.9B
$47M 1.73%
142,000
+42,000
+42% +$13.8M
JPM icon
12
CALL
JPMorgan Chase
JPM
$916B
$45.2M 1.66%
750,000
+250,000
+50% +$14.6M
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$11.9B
$39.7M 1.46%
550,000
+25,000
+5% +$1.64M
AIG icon
14
CALL
American International
AIG
$42.5B
$32.4M 1.19%
600,000
+100,000
+20% +$5.46M
TEVA icon
15
CALL
Teva Pharmaceuticals
TEVA
$40.4B
$32.3M 1.19%
600,000
-100,000
-14% -$5.3M
AUXL
16
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$29.9M 1.1%
1,000,000
-1,015,000
-50% -$21.5M
BAC icon
17
CALL
Bank of America
BAC
$429B
$29.8M 1.1%
1,750,000
-750,000
-30% -$11.9M
GM icon
18
CALL
General Motors
GM
$80.9B
$27.1M 1%
850,000
– –
XLI icon
19
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$32.2B
$26.6M 0.98%
+500,000
New +$26.8M
PCYC
20
DELISTED
PHARMACYCLICS INC
PCYC
$26.4M 0.97%
225,000
-45,000
-17% -$5.13M
GE icon
21
CALL
GE Aerospace
GE
$364B
$25.6M 0.94%
208,662
-104,331
-33% -$13M
VMC icon
22
CALL
Vulcan Materials
VMC
$36.8B
$24.1M 0.89%
400,000
+200,000
+100% +$12.6M
AVNR
23
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$23.8M 0.88%
2,000,000
– –
ALNY icon
24
Alnylam Pharmaceuticals
ALNY
$38.3B
$23.4M 0.86%
300,000
– –
INCY icon
25
Incyte
INCY
$25.4B
$21.6M 0.79%
440,000
+60,000
+16% +$3.01M
1
2 3 4 5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q3 2014 Portfolio in Review

As of Q3 2014, Artal Group held 104 positions worth $2.72B, up 9.8% from $2.47B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Artal Group's Q3 2014 filing shows 19 new, 17 increased, 17 reduced and 18 closed positions. Its largest new stake was Alibaba: 600,000 shares worth $53.3M. The largest sale was AUXILIUM PHARAMCEUTICALS INC, an estimated $21.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Artal Group's largest Q3 2014 buy was Alibaba: 600,000 shares worth $53.3M.
  • Artal Group added most to WW International in Q3 2014, an estimated $15.8M increase.
  • Artal Group's biggest Q3 2014 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $21.5M.
  • Artal Group fully exited Amazon in Q3 2014, selling an estimated $16.2M.
  • Artal Group's ten largest holdings make up 67% of its $2.72B portfolio in Q3 2014.
  • Artal Group opened 19 new positions and closed 18 in Q3 2014.
  • Artal Group's portfolio value rose 9.8% quarter-over-quarter to $2.72B.

Based on Artal Group's 13F filing for Q3 2014, filed 13 Nov 2014.